CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Early changes in HBV RNA serum levels are a predictor of HBeAg seroconversion in patients with chronic hepatitis B receiving treatment with Peg-interferon alpha-2a (40KD).
DOI 10.1055/s-0034-1386160
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF van Bömmel, A van Bömmel, H He, C Watt, D Deichsel, T Berg, S Böhm
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: We explored HBV RNA as a predictor of HBeAg seroconversion in patients with chronic hepatitis B (CHB). Methodology: 16 pairs of patients with HBeAg positive CHB (HBeAg seroconversion vs. non-seroconversion, matched by country and genotype) treated with Peg-IFN alpha-2a for 48 weeks and observed for additional 24 weeks were retrospectively studied. HBV RNA was quantified from serum samples collected at…
Zitieren
Zitierempfehlung
F van Bömmel, A van Bömmel, H He, C Watt, D Deichsel, T Berg, S Böhm (2014) Early changes in HBV RNA serum levels are a predictor of HBeAg seroconversion in patients with chronic hepatitis B receiving treatment with Peg-interferon alpha-2a (40KD). Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0034-1386160
Mit CareLit weiterarbeiten